Search company, investor...
ViOptix company logo


Founded Year



Series E | Alive

Total Raised


Last Raised

$3M | 13 yrs ago

About ViOptix

ViOptix is a medical device company that develops ODISsey Tissue Oximeter.

Headquarters Location

39655 Eureka Drive

Newark, California, 94560,

United States


Missing: ViOptix's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ViOptix's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ViOptix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ViOptix is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

ViOptix Patents

ViOptix has filed 133 patents.

The 3 most popular patent topics include:

  • Geometrical optics
  • Medical equipment
  • Spectroscopy
patents chart

Application Date

Grant Date


Related Topics





Application Date


Grant Date



Related Topics



Latest ViOptix News

United States Patent for Oximetry Probe with Electronically Selectable Tissue Depth Analysis Issued to Vioptix Inc

Nov 17, 2020

Alexandria–(Global IP News)–United States Patent for oximetry probe with electronically selectable tissue depth analysis has been issued to Vioptix Inc. This invention was developed by Bechtel Kate Leeann, Keating Jennifer Elizabeth and Coleridge Scott. The patent application number is 15/493,111.

ViOptix Frequently Asked Questions (FAQ)

  • When was ViOptix founded?

    ViOptix was founded in 1999.

  • Where is ViOptix's headquarters?

    ViOptix's headquarters is located at 39655 Eureka Drive, Newark.

  • What is ViOptix's latest funding round?

    ViOptix's latest funding round is Series E.

  • How much did ViOptix raise?

    ViOptix raised a total of $29.7M.

  • Who are the investors of ViOptix?

    Investors of ViOptix include Morningside Ventures, Vivo Capital, Channel Medical Partners, Canadian Medical Discoveries Fund, Lincoln Funds International and 6 more.

  • Who are ViOptix's competitors?

    Competitors of ViOptix include CSA Medical, TruTouch Technologies, Ornim Medical, ASL Analytical, AirXpanders and 13 more.

Compare ViOptix to Competitors


Tomophase Corporation was founded with the mission of developing solutions for minimally invasive diagnostic (MID) imaging. The company is using light to guide new ways of diagnosing diseases and has conceived major ideas for an optical MID imaging system

CSA Medical Logo
CSA Medical

CSA Medical is a developer of cryospray therapy platforms, truFreeze, and Rejuvenair.

Ornim Medical Logo
Ornim Medical

Ornim specializes in clinical research, development, and distribution of the highest quality medical devices in the field of tissue and cerebral blood flow and perfusion. The Company's leading product, the c-FLOW, is a bedside patient monitor based on the patented UTLight technology that provides physicians with unique monitoring solutions, revolutionizing individualized and personalized patient care.

ASL Analytical

ASL Analytical is a business-to-business company developing chemical monitors for the bio-manufacturing market. Using measurement technology, ASL is targeting game-changing advances in the development and production of biopharmaceuticals and other biological-based manufacturing markets.


NICO develops technology for the field of minimally invasive neurosurgery, including skull base and spinal surgery. The company's technology and products are designed and developed to impact patients' lives, families, caregivers, and health system providers. It provides patented technologies that integrate imaging and intervention for approaches to brain surgery. NICO was founded in 2007 and is based in Indianapolis, Indiana.


Nicast is a nano-tech company operatings in the field of tissue engineering, implantable bio-materials and advanced dosage forms. Nicast's matrices mimic biological tissue and therefore allow the creation of artificial organs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.